Editas Medicine Inc [NASDAQ: EDIT] gained 12.60% on the last trading session, reaching $2.86 price per share at the time.
Editas Medicine Inc represents 83.71 million in outstanding shares, while the company has a total market value of $239.42 million with the latest information. EDIT stock price has been found in the range of $2.535 to $3.07.
If compared to the average trading volume of 2.27M shares, EDIT reached a trading volume of 5693248 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Editas Medicine Inc [EDIT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EDIT shares is $3.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EDIT stock is a recommendation set at 2.57. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Editas Medicine Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 28, 2025. The new note on the price target was released on December 16, 2024, representing the official price target for Editas Medicine Inc stock. On December 13, 2024, analysts decreased their price target for EDIT shares from 11 to 3.
The Price to Book ratio for the last quarter was 3.84, with the Price to Cash per share for the same quarter was set at 2.64.
Trading performance analysis for EDIT stock
Editas Medicine Inc [EDIT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 30.00. With this latest performance, EDIT shares gained by 58.89% in over the last four-week period, additionally plugging by 118.32% over the last 6 months – not to mention a rise of 125.20% in the past year of trading.
Editas Medicine Inc [EDIT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Editas Medicine Inc [EDIT] shares currently have an operating margin of -578.30% and a Gross Margin at 82.37%. Editas Medicine Inc’s Net Margin is presently recorded at -701.06%.
Return on Equity for this stock declined to -71.37%, with Return on Assets sitting at -71.37%.
Editas Medicine Inc [EDIT]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EDIT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Editas Medicine Inc go to 27.74%.
An analysis of Institutional ownership at Editas Medicine Inc [EDIT]
There are presently around $57.56%, or 57.76% of EDIT stock, in the hands of institutional investors. The top three institutional holders of EDIT stocks are: VANGUARD GROUP INC with ownership of 8.03 million shares, which is approximately 9.7589%. BLACKROCK INC., holding 7.78 million shares of the stock with an approximate value of $$36.34 million in EDIT stocks shares; and BLACKROCK INC., currently with $$28.02 million in EDIT stock with ownership which is approximately 7.2895%.
